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“Direct link found between smoking
and lung cancer,” ran the headline in
the most influential real estate in all
American journalism: page one,
above the fold, in the New York Times.
But the story wasn’t Sir Richard
Doll’s 1952 study showing that
smokers are vastly more likely than
nonsmokers to develop lung cancer.
And it wasn’t the US Surgeon
General’s 1964 report declaring that
cigarettes cause lung cancer. The
subject was a 1996 report in Science,
detailing how one of the more than
40 carcinogens in cigarette smoke
causes mutations in p53, a gene
linked to lung cancer (and other
malignancies).
There’s no question that the
study was a tidy little piece of
molecular biology. But it’s rather
remarkable how some reporters
dressed up the finding to give it the
air of a revelation. The New York
Times report was propelled, among
other things, by the words of
anti-smoking law professor John
Banzhaf, who was quoted saying,
“This is very important in imposing
liability on the cigarette industry and
in protecting nonsmokers from
secondhand smoke.”
Dealing with a small but
interesting finding is always a
delicate balancing act. The trick is to
make it newsworthy without
overblowing its significance. Many in
the US media overreached on this
one by suggesting that, until now,
there has been no ‘smoking gun’
linking tobacco smoke to lung
cancer.
For starters, many stories
downplayed or ignored mounds of
previous studies, dating back to the
1950s, linking the carcinogen in
question, benzo(a)pyrene, to all sorts
of cancers. Many also ignored
previous molecular biology showing
that benzo(a)pyrene has been shown
to mutate p53 — and that p53
mutations have been found in many
lung cancer cells.
What was new was this nuance: in
cell culture, benzo(a)pyrene causes
the same mutations in p53 as are
found in about 60 % of all lung
cancers. But ignoring the previous
molecular studies, the Wall Street
Journal reported that “Until now, the
conviction that smoking causes lung
cancer has rested largely on
epidemiological evidence . . . and
toxicology.” The New York Times
noted that “While many scientists
have long been convinced by
statistical studies and animal
experiments that tobacco causes
cancer, a statistical association was
not in itself absolute proof.” But that
report, and others, didn’t mention
that, even with this much molecular
detail, the finding is still
fundamentally a correlation, not
“absolute proof” that would once
and for all deny the tobacco industry
its semantic argument about
causality and lung cancer.
It’s rather remarkable how some
reporters dressed up the finding
to give it the air of a revelation
Although reporters may be given
some latitude for skipping over the
scientific history of this field (which
was outlined in the Science article
itself ), they should have been more
aware of the legal implications of
the finding. Numerous news outlets
relied on the opinion of John
Banzhaf that the discovery would
make a huge difference in court
cases against tobacco companies, as
tobacco companies are now
deprived of their argument that
there’s no proof that smoking causes
cancer. “It’s confirmation of what
we have known before,” Banzhaf
told the Associated Press, “but it
makes it easier for us now to
demonstrate it in court.”
In fact, tobacco companies don’t
rely on that argument in court
anymore. They usually argue instead
that people know smoking is risky
(it says so on every pack of tobacco)
but they freely choose to keep at it
anyway. That’s why one of the
nation’s leading anti-tobacco
experts, Stanton Glantz at the
University of California at San
Francisco, told the Los Angeles Times,
“I think it’s a nice piece of science
that helps get at a mechanism but I
don’t see it as having a major public
health or legal or political impact.”
The head of the National Cancer
Institute’s tobacco control program,
Donald Shopland, echoed that
sentiment in other news reports.
The R.J. Reynolds Tobacco
Company was so delighted to read
Glantz’s words, that it sent out a
press release quoting him. And
Glantz says, for once, the tobacco
company got it right. Even so,
tobacco stock prices dropped sharply
on the day the news reports appeared
(though there was other, unrelated,
bad news on the legal front that day
for the tobacco industry).
Reporters who cover tobacco
regularly were more careful with the
story. Doug Levy at USA Today
noted in his short report that
researchers had previously identified
p53 mutations in smoking-induced
lung cancers. The San Francisco
Examiner, on the other hand, made
an embarrassing stab at explaining
the story in an editorial: “Our bodies
are built from millions of tiny cells,”
it begins. “Each has a nucleus.
Inside, bathed in DNA, are
microscopic chromosomes encrusted
with itsy-bitsy doodads called
genes.” The editorial ends with a
simple word of advice about
smoking that the writer should have
taken to heart several paragraphs
earlier: “Quit.”
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